RASSF1 and hepatocellular carcinoma: Rates of hypermethylation of RASSF1A, APC, BVES, TIMP3, GSTP1, and HOXA9 promoters in HCC patients, LC patients, CHB patients, and healthy individuals are shown in Table 2.